Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats

Brain Research

Volumn 1583, Issue 1, 2014, Pages 1-11

  Sárvári, Miklós ^a   Deli, Levente ^b   Kocsis, Pal ^c   Márk, László ^c   Maász, Gábor ^c   Hrabovszky, Erik ^a   Kalló, Imre ^a,d   Gajári, Dávid ^b   Vastagh, Csaba ^a   Siimegi, Bálazs ^c   Tihanyi, Károly ^b   Liposits, Zsolt ^a,d  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

Author keywords

Dopamine; Estradiol; Estrogen receptor alpha; Estrogen receptor beta; Mesocortical pathway; Rat

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; ESTRADIOL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; 3,4 DIHYDROXYPHENYLACETIC ACID; DEXAMPHETAMINE; DIARYLPROPIONITRILE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE UPTAKE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LACTONE; NITRILE; OXYGEN; PROPIONIC ACID DERIVATIVE; 16ALPHA LACTONE ESTRADIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MESOCORTICAL DOPAMINERGIC SYSTEM; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VENTRAL TEGMENTUM; AGONISTS; ANIMAL; BLOOD; BRAIN CIRCULATION; DRUG EFFECTS; METABOLISM; OVARIECTOMY; PHYSIOLOGY; WISTAR RAT; ADULT; ANIMAL CELL; ANIMAL TISSUE; NEUROMODULATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REWARD;

ANIMALIA; RATTUS; RODENTIA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CEREBROVASCULAR CIRCULATION; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; LACTONES; NITRILES; OVARIECTOMY; OXYGEN; PREFRONTAL CORTEX; PROPIONATES; RATS, WISTAR; RECEPTORS, DOPAMINE; VENTRAL TEGMENTAL AREA;

EID: 84921276576     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.06.020     Document Type: Article

References (74)

1. Arnsten, A.F.T., et al., 1995. Dopamine D2 receptor mechanisms contribute to age-related cognitive decline - The effects of quinpirole on memory and motor-performance in monkeys. J. Neurosci. 15 (5), 3429-3439.
2. Axelrod, J., 1977. Nonstriatal dopaminergic neurons: Section I. Mesocortical dopaminergic neurons: introduction: mesocortical dopaminergic neurons. Adv. Biochem. Psychopharmacol. 16, 1-3.
3. Bannon, M.J., Roth, R.H., 1983. Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35 (1), 53-68.
4. Becker, J.B., Rudick, C.N., 1999. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study Pharmacol. Biochem. Behav. 64 (1), 53-57.
5. Berger, B., et al., 1976. Dopaminergic innervation of the rat prefrontal cortex: A fluorescence histochemical study. Brain Res. 106 (1), 133-145.
6. Bosse, R., Rivest, R., Di Paolo, T., 1997. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res. Mol. Brain Res. 46 (1-2), 343-346.
7. Boyd, K.N., Mailman, R.B., 2012. Dopamine receptor signaling and current and future antipsychotic drugs. Handb. Exp. Pharmacol. (212), 53-86.
8. Bruns, A., et al., 2009. Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats. Magn. Reson. Med. 61 (6), 1451-1458.
9. Bustin, S.A., et al., 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55 (4), 611-622.
10. Cagampang, F.R., et al., 1991. Involvement of ovarian steroids and endogenous opioids in the fasting-induced suppression of pulsatile LH release in ovariectomized rats. J. Endocrinol. 129 (3), 321-328.
11. Cai, J.X., Arnsten, A.F., 1997. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J. Pharmacol. Exp. Ther. 283 (1), 183-189.
12. Carlsson, A., Lindqvist, M., 1963. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140-144.
13. Chavez, C., et al., 2011. Differential effect of amphetamine on c- fos expression in female aromatase knockout (ArKO) mice compared to wildtype controls. Psychoneuroendocrinology 36 (5), 761-768.
14. Chen, Y.C., et al., 1997. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. 38 (3), 389-398.
15. Chowdhury, R., et al., 2012. Dopamine modulates episodic memory persistence in old age. J. Neurosci. 32 (41), 14193-14204.
16. Chowdhury, R., et al., 2013. Dopamine restores reward prediction errors in old age. Nat. Neurosci. 16 (5), 648-653.
17. Cousins, D.A., Butts, K., Young, A.H., 2009. The role of dopamine in bipolar disorder. Bipolar Disord. 11 (8), 787-806.
18. Creutz, L.M., Kritzer, M.F., 2002. Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J. Comp. Neurol. 446 (3), 288-300.
19. Creutz, L.M., Kritzer, M.F., 2004. Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats. J. Comp. Neurol. 476 (4), 348-362.
20. Dahlstroem, A., Fuxe, K., 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. Suppl. 232, S1-S55.
21. Dahlstroem, A., et al., 1964. Ascending systems of catecholamine neurons from the lower brain stem. Acta Physiol. Scand. 62, 485-486.
22. Dazzi, L., et al., 2007. Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat. Neuropsychopharmacology 32 (4), 892-901.
23. Deecher, D., et al., 2008. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 33 (1), 3-17.
24. Di Paolo, T., Rouillard, C., Bedard, P., 1985. 17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur. J. Pharmacol. 117 (2), 197-203.
25. Dixon, A.L., et al., 2005. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48 (2), 236-245.
26. Dubal, D.B., Wise, P.M., 2001. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 142 (1), 43-48.
27. Easton, N., et al., 2007. Differential effects of the d- And l- isomers of amphetamine on pharmacological MRI BOLD contrast in the rat. Psychopharmacology 193 (1), 11-30.
28. Evans, S.M., 2007. The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp. Clin. Psychopharmacol. 15 (5), 418-426.
29. Feenstra, M.G., Botterblom, M.H., 1996. Rapid sampling of extracellular dopamine in the rat prefrontal cortex during food consumption, handling and exposure to novelty. Brain Res. 742 (1-2), 17-24.
30. Ferrer, J.M., et al., 1983. Effects of agonists and antagonists of D1 and D2 do pamine receptors on self-stimulation of the medial prefrontal cortex in the rat. Pharmacol. Biochem. Behav. 19 (2), 211-217.
31. Fischer, J.F., Cho, A.K., 1979. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208 (2), 203-209.
32. Floresco, S.B., 2013. Prefrontal dopamine and behavioral flexibility: shifting from an inverted-U toward a family of functions. Front. Neurosci. 7, 62.
33. Gao, M., et al., 2007. Functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area. J. Neurosci. 27 (20), 5414-5421.
34. Hillisch, A., et al., 2004. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design. Mol. Endocrinol. 18 (7), 1599-1609.
35. Horn, A.S., Cuello, A.C., Miller, R.J., 1974. Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity. J. Neurochem. 22 (2), 265-270.
36. Howes, O.D., Kapur, S., 2009. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 35 (3), 549-562.
37. Hsu, Y.H., et al., 2008. Neuronal dysfunction of a long projecting multisynaptic pathway in response to methamphetamine using manganese-enhanced MRI. Psychopharmacology 196 (4), 543-553.
38. Inagaki, T., Gautreaux, C., Luine, V., 2010. Acute estrogen treatment facilitates recognition memory consolidation and alters monoamine levels in memory-related brain areas. Horm. Behav. 58 (3), 415-426.
39. Jacobs, E., D'Esposito, M., 2011. Estrogen shapes dopamine- dependent cognitive processes: implications for women's health. J. Neurosci. 31 (14), 5286-5293.
40. Kocsis, P., et al., 2013. Effect of tolperisone on the resting brain and on evoked responses, an phMRI BOLD study. Brain Res. Bull. 99, 34-40.
41. Kritzer, M.F., 1997. Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J. Comp. Neurol. 379 (2), 247-260.
42. Kritzer, M.F., 2002. Regional, laminar, and cellular distribution of immunoreactivity for ER alpha and ER beta in the cerebral cortex of hormonally intact, adult male and female rats. Cereb. Cortex. 12 (2), 116-128.
43. Lammel, S., Tye, K.M., Warden, M.R., 2013. Progress in understanding mood disorders: optogenetic dissection of neural circuits. Genes Brain Behav..
44. Mizoguchi, K., et al., 2009. Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats. Neuroscience 162 (4), 1192-1201.
45. Oades, R.D., Halliday, G.M., 1987. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res. 434 (2), 117-165.
46. Phillipson, O.T., 1979. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat. J. Comp. Neurol. 187 (1), 117-143.
47. Preece, M.A., et al., 2007. Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain. Synapse 61 (11), 925-932.
48. Puig, M.V., Miller, E.K., 2012. The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning. Neuron 74 (5), 874-886.
49. Quinones-Jenab, V., 2006. Why are women from Venus and men from Mars when they abuse cocaine?. Brain Res. 1126 (1), 200-203.
50. Rapp, P.R., Morrison, J.H., Roberts, J.A., 2003. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J. Neurosci. 23 (13), 5708-5714.
51. Richardson, N.R., Gratton, A., 1998. Changes in medial prefrontal cortical dopamine levels associated with response-contingent food reward: An electrochemical study in rat. J. Neurosci. 18 (21), 9130-9138.
52. Sakamoto, Y., Suga, S., Sakuma, Y., 1993. Estrogen-sensitive neurons in the female rat ventral tegmental area: A dual route for the hormone action. J. Neurophysiol. 70 (4), 1469-1475.
53. Sarvari, M., et al., 2010. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology 151 (8), 3847-3862.
54. Sarvari, M., et al., 2010. Gene expression profiling identifies key estradiol targets in the frontal cortex of the rat. Endocrinology 151 (3), 1161-1176.
55. Sarvari, M., et al., 2011. Estrogens regulate neuroinflammatory genes via estrogen receptors alpha and beta in the frontal cortex of middle-aged female rats. J. Neuroinflamm. 8, 82.
56. Schwarz, A.J., et al., 2007. Pharmacological modulation of functional connectivity: The correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A. Magn. Reson. Imaging 25 (6), 811-820.
57. Sesack, S.R., Carr, D.B., 2002. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol. Behav. 77 (4-5), 513-517.
58. Shughrue, P.J., Lane, M.V., Merchenthaler, I., 1997. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388 (4), 507-525.
59. Sulzer, D., Rayport, S., 1990. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action. Neuron 5 (6), 797-808.
60. Sun, J., et al., 2003. Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile. Mol. Endocrinol. 17 (2), 247-258.
61. Swanson, L.W., 1982. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9 (1-6), 321-353.
62. Tzschentke, T.M., Schmidt, W.J., 2000. Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit. Rev. Neurobiol. 14 (2), 131-142.
63. Vijayraghavan, S., et al., 2007. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 10 (3), 376-384.
64. Volkow, N.D., et al., 2004. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9 (6), 557-569.
65. Volkow, N.D., et al., 2011. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol. Psychiatry 16 (11), 1147-1154.
66. Volkow, N.D., et al., 2011. Reduced metabolism in brain control networks following cocaine-cues exposure in female cocaine abusers. Plos One 6 (2), e16-e73.
67. Watson, G., Paxinos, C., 1998. The rat brain in stereotaxic coordinates. Academic Press.
68. Weinberger, D.R., Berman, K.F., Chase, T.N., 1988. Mesocortical dopaminergic function and human cognition. Ann. N.Y. Acad. Sci. 537, 330-338.
69. Williams, J.M., et al., 2010. Chronic exposure to manganese alters brain responses to amphetamine: A pharmacological magnetic resonance imaging study. Toxicol. Sci. 114 (2), 310-322.
70. Williams, S.M., Goldman-Rakic, P.S., 1998. Widespread origin of the primate mesofrontal dopamine system. Cereb. Cortex 8 (4), 321-345.
71. Xiao, L., Becker, J.B., 1994. Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci. Lett. 180 (2), 155-158.
72. Xiao, L., Jackson, L.R., Becker, J.B., 2003. The effect of estradiol in the striatum is blocked by ICI 182, 780 but not tamoxifen: pharmacological and behavioral evidence. Neuroendocrinology 77 (4), 239-245.
73. Zahrt, J., et al., 1997. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17 (21), 8528-8535.
74. Zhang, D., et al., 2008. Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine. Psychopharmacology 199 (4), 625-635.